Seventy-five percent of all COVID-19 vaccine trials around the world are using Schott's glass vials, according to the manufacturer. To meet the growing demand, their employees are working around ...

a pharmaceutical glass vial for the filling line performance; SCHOTT Type I plus, a pharmaceutical glass vial for drug formulations; SCHOTT TopLyo, a pharmaceutical glass vial to avoid fogging for ...

SCHOTT Pharma also reported that its expansion ... supply from its new production site in Serbia for ampoules and vials, which is slated to begin in the middle of the year. This article was ...

Next expansion milestone achieved: SCHOTT Pharma opens production facility in Serbia to strengthen competitiveness in Europe After a double-digit million euro investment and less than 1.5 years of ...